📣 Help Shape the Future of UKRI's Gateway to Research (GtR)

We're improving UKRI's Gateway to Research and are seeking your input! If you would be interested in being interviewed about the improvements we're making and to have your say about how we can make GtR more user-friendly, impactful, and effective for the Research and Innovation community, please email gateway@ukri.org.

Protocol of a randomized, double-blind, placebo-controlled, parallel-group, multicentre study of the efficacy and safety of nicotinamide in patients with Friedreich ataxia (NICOFA). (2019)

First Author: Reetz K

Attributed to: Applying epigenetic modifying drugs to treat Friedreich's Ataxia funded by MRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1186/s42466-019-0038-9

PubMed Identifier: 33324899

Publication URI: http://europepmc.org/abstract/MED/33324899

Type: Journal Article/Review

Volume: 1

Parent Publication: Neurological research and practice

ISSN: 2524-3489